NasdaqCM - Delayed Quote USD

Rezolute, Inc. (RZLT)

4.2250
+0.1050
+(2.55%)
At close: June 2 at 4:00:00 PM EDT
4.2400
+0.01
+(0.36%)
After hours: June 2 at 7:32:17 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
77,146
70,423
55,990
41,612
22,379
Operating Income
-77,146
-70,423
-55,990
-41,612
-22,379
Net Non Operating Interest Income Expense
5,078
4,870
4,208
-1,727
-312
Other Income Expense
-930
-2,906
-5
2,279
1,789
Pretax Income
-72,998
-68,459
-51,787
-41,060
-20,902
Net Income Common Stockholders
-72,998
-68,459
-51,787
-41,060
-20,902
Average Dilution Earnings
--
--
0
-4,070
0
Diluted NI Available to Com Stockholders
-72,998
-68,459
-51,787
-45,130
-20,902
Basic EPS
-1.16
-1.33
-1.01
-2.26
-2.72
Diluted EPS
-1.16
-1.33
-1.01
-2.32
-2.72
Basic Average Shares
65,482.5010
51,465
51,187
18,197
7,671
Diluted Average Shares
65,482.5010
51,465
51,187
19,487
7,671
Total Operating Income as Reported
-77,146
-70,423
-55,990
-41,843
-22,894
Total Expenses
77,146
70,423
55,990
41,612
22,379
Net Income from Continuing & Discontinued Operation
-72,998
-68,459
-51,787
-41,060
-20,902
Normalized Income
-72,068
-65,553
-51,782
-43,339
-22,691
Interest Income
5,078
4,870
4,208
80
63
Interest Expense
--
--
0
1,807
375
Net Interest Income
5,078
4,870
4,208
-1,727
-312
EBIT
-77,146
-70,423
-55,990
-39,253
-20,527
EBITDA
-77,116
-70,387
-55,960
-39,240
-20,514
Reconciled Depreciation
30
36
30
13
13
Net Income from Continuing Operation Net Minority Interest
-72,998
-68,459
-51,787
-41,060
-20,902
Total Unusual Items Excluding Goodwill
-930
-2,906
-5
2,279
1,789
Total Unusual Items
-930
-2,906
-5
2,279
1,789
Normalized EBITDA
-76,186
-67,481
-55,955
-41,519
-22,303
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 1/14/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LXEO Lexeo Therapeutics, Inc.
2.7200
0.00%
 
LRMR Larimar Therapeutics, Inc.
2.2050
-2.00%
 
FULC Fulcrum Therapeutics, Inc.
6.96
+1.24%
 
VERA Vera Therapeutics, Inc.
31.74
+67.49%
 
CRNX Crinetics Pharmaceuticals, Inc.
31.88
+4.49%
 
CMMB Chemomab Therapeutics Ltd.
1.3500
+2.27%
 
ZURA Zura Bio Limited
1.0100
0.00%
 
CLYM Climb Bio Inc
1.1800
0.00%
 
TRVI Trevi Therapeutics, Inc.
6.32
-3.00%
 
ANAB AnaptysBio, Inc.
21.86
-1.66%